Standardising CLL patient stratification globally

Kostas Stamatopoulos

Kostas Stamatopoulos, MD, PhD from the Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece provides information on how he aims to ensure standardisation across the world when detecting mutations in order to stratify patients. This interview was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.

Share this video